Long-lasting improvement after septal myectomy for hypertrophic obstructive cardiomyopathy

Annals of Thoracic Surgery

Volumn 69, Issue 6, 2000, Pages 1732-1735

  Merrill, Walter H ^a   Friesinger, Gottlieb C ^a   Graham Jr , Thomas P ^a   Byrd III, Benjamin F ^a   Drinkwater Jr , Davis C ^a   Christian, Karla G ^a   Bender Jr , Harvey W ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; MUSCLE RESECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0033932185     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(00)01314-X     Document Type: Article

References (13)

1. Morrow A.G. Hypertrophic subaortic stenosis. Operative methods utilized to relieve left ventricular outflow obstruction. J Thorac Cardiovasc Surg. 76:1978;423-430.
2. Robbins R.C., Stinson E.B. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 111:1996;586-594.
3. McIntosh C.L., Greenberg G.J., Maron B.J., Leon M.B., Cannon R.O. III, Clark R.E. Clinical and hemodynamic results after mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy. Ann Thorac Surg. 47:1989;236-246.
4. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 346:1995;211-214.
5. Seggewiss H., Gleichmann U., Faber L., Fassbender D., Schmidt H.K., Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy acute results and 3-month follow-up in 25 patients . J Am Coll Cardiol. 31:1998;252-258.
6. Fananapazir L., McAreavey D. Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms. J Am Coll Cardiol. 31:1998;259-264.
7. Wigle E.D., Sasson Z., Henderson M.A., et al. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis. 28:1985;1-83.
8. Schulte H.D., Bircks W.H., Loesse B., Godehardt E.A.J., Schwartzkopff B. Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. Late results up to twenty-five years. J Thorac Cardiovasc Surg. 106:1993;709-717.
9. McCully R.B., Nishimura R.A., Tajik A.J., Schaff H.V., Danielson G.K. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation. 94:1996;467-471.
10. Nishimura R.A., Trusty J.M., Hayes D.L., et al. Dual-chamber pacing for hypertrophic cardiomyopathy. A randomized, double-blind, crossover trial. J Am Coll Cardiol. 29:1997;435-441.
11. Maron B.J., Nishimura R.A., McKenna W.J., Rakowski H., Josephson M.E., Kieval R.S. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study. Circulation. 99:1999;2927-2933.
12. Cooley D.A., Wukasch D.C., Leachman R.D. Mitral valve replacement for idiopathic hypertrophic subaortic stenosis results in 27 patients . J Cardiovasc Surg. 17:1976;380-387.
13. Stone C.D., McIntosh C.L., Hennein H.A., Maron B.J., Clark R.E. Operative treatment of pediatric obstructive hypertrophic cardiomyopathy a 26-year experience . Ann Thorac Surg. 56:1993;1308-1314.